MERS-CoV-IN-1

• UNSPSC Description:

  MERS-CoV-IN-1 exhibits excellent inhibitory activity against coronavirus. MERS-CoV-IN-1 is useful as a pharmaceutical composition for preventing coronavirus-induced diseases (MERS-CoV and SARS) (extracted from patent WO2018174442A1, compound 1)[1].

• Target Antigen:

  SARS-CoV

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/mers-cov-in-1.html

• Solubility:

  DMSO : 250 mg/mL (ultrasonic)

• Smiles:

  NC1=C(C=CC=C1)COC(C=C2)=CC=C2OC3=CC=CC=C3

• Molecular Weight:

  291.34

• References & Citations:

  [1]Compound for treating diseases caused by coronavirus infection. Patent WO2018174442A1.

• Shipping Conditions:

  Room Temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2245697-92-9